Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health

Thomas H. Schindler, Heinrich R. Schelbert, Alessandra Quercioli, Vasken Dilsizian

Research output: Contribution to journalArticle

Abstract

Positron emission tomography (PET) myocardial perfusion imaging in concert with tracer-kinetic modeling affords the assessment of regional myocardial blood flow (MBF) of the left ventricle in absolute terms (milliliters per gram per minute). Assessment of MBF both at rest and during various forms of vasomotor stress provides insight into early and subclinical abnormalities in coronary arterial vascular function and/or structure, noninvasively. The noninvasive evaluation and quantification of MBF and myocardial flow reserve (MFR) extend the scope of conventional myocardial perfusion imaging from detection of end-stage, advanced, and flow-limiting, epicardial coronary artery disease (CAD) to early stages of atherosclerosis or microvascular dysfunction. Recent studies have shown that impaired hyperemic MBF or MFR with PET, with or without accompanying CAD, is predictive of increased relative risk of death or progression of heart failure. Quantitative approaches that measure MBF with PET identify multivessel CAD and offer the opportunity to monitor responses to lifestyle and/or risk factor modification and to therapeutic interventions. Whether improvement or normalization of hyperemic MBF and/or the MFR will translate to improvement in long-term cardiovascular outcome remains clinically untested. In the meantime, absolute measures of MBF with PET can be used as a surrogate marker for coronary vascular health, and to monitor therapeutic interventions. Although the assessment of myocardial perfusion with PET has become an indispensable tool in cardiac research, it remains underutilized in clinical practice. Individualized, image-guided cardiovascular therapy may likely change this paradigm in the near future.

Original languageEnglish (US)
Pages (from-to)623-640
Number of pages18
JournalJACC: Cardiovascular Imaging
Volume3
Issue number6
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Positron-Emission Tomography
Coronary Artery Disease
Health
Myocardial Perfusion Imaging
Blood Vessels
Regional Blood Flow
Heart Ventricles
Life Style
Atherosclerosis
Therapeutics
Heart Failure
Perfusion
Biomarkers
Research

Keywords

  • cardiovascular disease prevention
  • coronary artery disease
  • coronary circulation
  • endothelium y microcirculation
  • myocardial blood flow
  • myocardial flow reserve
  • positron emission tomography

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. / Schindler, Thomas H.; Schelbert, Heinrich R.; Quercioli, Alessandra; Dilsizian, Vasken.

In: JACC: Cardiovascular Imaging, Vol. 3, No. 6, 2010, p. 623-640.

Research output: Contribution to journalArticle

Schindler, Thomas H. ; Schelbert, Heinrich R. ; Quercioli, Alessandra ; Dilsizian, Vasken. / Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. In: JACC: Cardiovascular Imaging. 2010 ; Vol. 3, No. 6. pp. 623-640.
@article{47fe59467ea94c15b36fe676fee54964,
title = "Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health",
abstract = "Positron emission tomography (PET) myocardial perfusion imaging in concert with tracer-kinetic modeling affords the assessment of regional myocardial blood flow (MBF) of the left ventricle in absolute terms (milliliters per gram per minute). Assessment of MBF both at rest and during various forms of vasomotor stress provides insight into early and subclinical abnormalities in coronary arterial vascular function and/or structure, noninvasively. The noninvasive evaluation and quantification of MBF and myocardial flow reserve (MFR) extend the scope of conventional myocardial perfusion imaging from detection of end-stage, advanced, and flow-limiting, epicardial coronary artery disease (CAD) to early stages of atherosclerosis or microvascular dysfunction. Recent studies have shown that impaired hyperemic MBF or MFR with PET, with or without accompanying CAD, is predictive of increased relative risk of death or progression of heart failure. Quantitative approaches that measure MBF with PET identify multivessel CAD and offer the opportunity to monitor responses to lifestyle and/or risk factor modification and to therapeutic interventions. Whether improvement or normalization of hyperemic MBF and/or the MFR will translate to improvement in long-term cardiovascular outcome remains clinically untested. In the meantime, absolute measures of MBF with PET can be used as a surrogate marker for coronary vascular health, and to monitor therapeutic interventions. Although the assessment of myocardial perfusion with PET has become an indispensable tool in cardiac research, it remains underutilized in clinical practice. Individualized, image-guided cardiovascular therapy may likely change this paradigm in the near future.",
keywords = "cardiovascular disease prevention, coronary artery disease, coronary circulation, endothelium y microcirculation, myocardial blood flow, myocardial flow reserve, positron emission tomography",
author = "Schindler, {Thomas H.} and Schelbert, {Heinrich R.} and Alessandra Quercioli and Vasken Dilsizian",
year = "2010",
doi = "10.1016/j.jcmg.2010.04.007",
language = "English (US)",
volume = "3",
pages = "623--640",
journal = "JACC: Cardiovascular Imaging",
issn = "1936-878X",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health

AU - Schindler, Thomas H.

AU - Schelbert, Heinrich R.

AU - Quercioli, Alessandra

AU - Dilsizian, Vasken

PY - 2010

Y1 - 2010

N2 - Positron emission tomography (PET) myocardial perfusion imaging in concert with tracer-kinetic modeling affords the assessment of regional myocardial blood flow (MBF) of the left ventricle in absolute terms (milliliters per gram per minute). Assessment of MBF both at rest and during various forms of vasomotor stress provides insight into early and subclinical abnormalities in coronary arterial vascular function and/or structure, noninvasively. The noninvasive evaluation and quantification of MBF and myocardial flow reserve (MFR) extend the scope of conventional myocardial perfusion imaging from detection of end-stage, advanced, and flow-limiting, epicardial coronary artery disease (CAD) to early stages of atherosclerosis or microvascular dysfunction. Recent studies have shown that impaired hyperemic MBF or MFR with PET, with or without accompanying CAD, is predictive of increased relative risk of death or progression of heart failure. Quantitative approaches that measure MBF with PET identify multivessel CAD and offer the opportunity to monitor responses to lifestyle and/or risk factor modification and to therapeutic interventions. Whether improvement or normalization of hyperemic MBF and/or the MFR will translate to improvement in long-term cardiovascular outcome remains clinically untested. In the meantime, absolute measures of MBF with PET can be used as a surrogate marker for coronary vascular health, and to monitor therapeutic interventions. Although the assessment of myocardial perfusion with PET has become an indispensable tool in cardiac research, it remains underutilized in clinical practice. Individualized, image-guided cardiovascular therapy may likely change this paradigm in the near future.

AB - Positron emission tomography (PET) myocardial perfusion imaging in concert with tracer-kinetic modeling affords the assessment of regional myocardial blood flow (MBF) of the left ventricle in absolute terms (milliliters per gram per minute). Assessment of MBF both at rest and during various forms of vasomotor stress provides insight into early and subclinical abnormalities in coronary arterial vascular function and/or structure, noninvasively. The noninvasive evaluation and quantification of MBF and myocardial flow reserve (MFR) extend the scope of conventional myocardial perfusion imaging from detection of end-stage, advanced, and flow-limiting, epicardial coronary artery disease (CAD) to early stages of atherosclerosis or microvascular dysfunction. Recent studies have shown that impaired hyperemic MBF or MFR with PET, with or without accompanying CAD, is predictive of increased relative risk of death or progression of heart failure. Quantitative approaches that measure MBF with PET identify multivessel CAD and offer the opportunity to monitor responses to lifestyle and/or risk factor modification and to therapeutic interventions. Whether improvement or normalization of hyperemic MBF and/or the MFR will translate to improvement in long-term cardiovascular outcome remains clinically untested. In the meantime, absolute measures of MBF with PET can be used as a surrogate marker for coronary vascular health, and to monitor therapeutic interventions. Although the assessment of myocardial perfusion with PET has become an indispensable tool in cardiac research, it remains underutilized in clinical practice. Individualized, image-guided cardiovascular therapy may likely change this paradigm in the near future.

KW - cardiovascular disease prevention

KW - coronary artery disease

KW - coronary circulation

KW - endothelium y microcirculation

KW - myocardial blood flow

KW - myocardial flow reserve

KW - positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=77956658504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956658504&partnerID=8YFLogxK

U2 - 10.1016/j.jcmg.2010.04.007

DO - 10.1016/j.jcmg.2010.04.007

M3 - Article

C2 - 20541718

AN - SCOPUS:77956658504

VL - 3

SP - 623

EP - 640

JO - JACC: Cardiovascular Imaging

JF - JACC: Cardiovascular Imaging

SN - 1936-878X

IS - 6

ER -